Exploration of the mechanisms of HLWDD on skeletal muscle lesions under the influence of diabetes based on bioinformatics analysis and experimental validation

基于生物信息学分析和实验验证,探讨高脂高糖饮食(HLWDD)在糖尿病影响下对骨骼肌损伤的机制

阅读:2

Abstract

OBJECTIVE: To investigate the molecular mechanisms of Huanglian Wendan Decoction in treating type 2 diabetes mellitus-associated skeletal muscle lesions via integrated bioinformatics and experimental validation. METHODS: T2DM-related skeletal muscle microarray datasets from the GEO database were analyzed to identify differentially expressed genes (n = 3309). Apoptosis-related targets (n = 887) and T2DM-related targets (n = 3106) were retrieved from GeneCards, and intersection analysis yielded 96 shared targets. Protein-protein interaction networks were constructed using STRING and Cytoscape; via CytoHubba, 10 core targets were first screened based on degree centrality. ROC curves were further used to validate the diagnostic efficacy of these 10 core genes, ultimately confirming 5 key targets (EGFR, PTEN, MDM2, TRAF6, and CCL5) with valid diagnostic value. Functional enrichment analysis revealed pathways including cysteine-type endopeptidase activity regulation and pyroptosis, while immune infiltration analysis linked the key targets to immune cell modulation. Molecular docking was used to assess the interactions between HLWDD compounds and the 5 key targets. A T2DM rat model was established using a high-fat diet combined with streptozotocin; biochemical parameters and skeletal muscle morphology were evaluated, and the protein expression of the 5 key targets was analyzed using immunohistochemistry and western blotting. RESULTS: HLWDD significantly reduced HbA1c, blood lipid, glucose, and renal dysfunction markers (P < 0.05), improved skeletal muscle histology, and downregulated core target proteins. Bioinformatics has highlighted the association of core genes with apoptosis and immune responses. ROC analysis demonstrated strong diagnostic potential (AUC > 0.5). CONCLUSION: HLWDD alleviated T2DM skeletal muscle injury by modulating apoptosis-related pathways and immune interactions, as supported by multi-omics and experimental validation. This study provides novel therapeutic targets and mechanistic insights into HLWDD for T2DM management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。